Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313346312> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4313346312 endingPage "23" @default.
- W4313346312 startingPage "14" @default.
- W4313346312 abstract "Background and Objectives: Carbapenem-resistant Pseudomonas aeruginosa, are among the top tier of the list of antibiotic-resistant priority pathogens that pose the greatest threat to human health. In recent years, the rate of carbapenem resistance in Pseudomonas aeruginosa has increased worldwide and has become of great concern since it significantly restricts the therapeutic options for patients. Therefore this study was undertaken to determine the antibiotic susceptibility profile of the clinical isolate of Carbapenem-resistant Pseudomonas aeruginosa.
 Methodology: A total of five hundred (500) clinical samples were collected from patient’s attending Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State (AFEUTHA). The collected samples were analyzed for the presence of Pseudomonas aeruginosa using standard microbiological techniques for isolation and characterization of bacteria. Further strain confirmation was performed using VITEK 2 System. Phenotypic detection of Carbapenem-resistant Pseudomonas aeruginosa was performed using Modified Hodge testing. Antibiotic susceptibility was performed by employing Kirby-Bauer disk diffusion method and the results were interpreted using the Clinical Laboratory Standard Institute (CLSI) zone diameter breakpoints.
 Results: The occurrence rate of Pseudomonas aeruginosa in clinical samples accounted for 119(23.8%) consisting of a high proportion from urine sample 81(27.4%) followed by wound swabs 13(25.5%), high vaginal swabs 17(20.7) while the least occurrence rate was observed against catheter tips 5(12.8%) and sputum 3(9.4%). Modified Hodge testing revealed 31(6.2%) carbapenem-resistant Pseudomonas aeruginosa comprising of high proportion of 24(8.1%) from urine samples followed by wound swab 5(9.8%) while Carbapenem-resistant Pseudomonas aeruginosa was absent in High Vaginal Swab recording 0(0.0%). Carbapenem-resistant Pseudomonas aeruginosa isolates were highly resistant to amoxicillin-clavulanic 100%, colistin 100%, tetracycline 100%, nitrofurantoin 70.8%, aztreonam 87.5% but were susceptible to nalixidic acid 50.0 %, ofloxacin 75.0%, and ciprofloxacin 100%.
 Conclusion: As in-vitro susceptibility of carbapenem-resistant Pseudomonas aeruginosa isolates to ofloxacin and ciprofloxacin is known, their judicious utilization will accelerate a significant improvement in the patient's condition. As such, there is a substantial need for the evaluation of a wide spectrum and new therapies in different classes to counteract this imminent crisis of resistance among Carbapenem-resistant Pseudomonas aeruginosa." @default.
- W4313346312 created "2023-01-06" @default.
- W4313346312 creator A5020382465 @default.
- W4313346312 creator A5023720988 @default.
- W4313346312 creator A5038981643 @default.
- W4313346312 creator A5052098869 @default.
- W4313346312 creator A5063133200 @default.
- W4313346312 creator A5066802959 @default.
- W4313346312 date "2022-12-26" @default.
- W4313346312 modified "2023-10-01" @default.
- W4313346312 title "Antibiotic Susceptibility Profile of Clinical Isolate of Carbapenem-Resistant Pseudomonas aeruginosa" @default.
- W4313346312 doi "https://doi.org/10.9734/sajrm/2022/v14i2267" @default.
- W4313346312 hasPublicationYear "2022" @default.
- W4313346312 type Work @default.
- W4313346312 citedByCount "1" @default.
- W4313346312 countsByYear W43133463122023 @default.
- W4313346312 crossrefType "journal-article" @default.
- W4313346312 hasAuthorship W4313346312A5020382465 @default.
- W4313346312 hasAuthorship W4313346312A5023720988 @default.
- W4313346312 hasAuthorship W4313346312A5038981643 @default.
- W4313346312 hasAuthorship W4313346312A5052098869 @default.
- W4313346312 hasAuthorship W4313346312A5063133200 @default.
- W4313346312 hasAuthorship W4313346312A5066802959 @default.
- W4313346312 hasBestOaLocation W43133463121 @default.
- W4313346312 hasConcept C142724271 @default.
- W4313346312 hasConcept C2776301714 @default.
- W4313346312 hasConcept C2776685102 @default.
- W4313346312 hasConcept C2777637488 @default.
- W4313346312 hasConcept C2781069245 @default.
- W4313346312 hasConcept C501593827 @default.
- W4313346312 hasConcept C523546767 @default.
- W4313346312 hasConcept C54355233 @default.
- W4313346312 hasConcept C71924100 @default.
- W4313346312 hasConcept C86803240 @default.
- W4313346312 hasConcept C89423630 @default.
- W4313346312 hasConceptScore W4313346312C142724271 @default.
- W4313346312 hasConceptScore W4313346312C2776301714 @default.
- W4313346312 hasConceptScore W4313346312C2776685102 @default.
- W4313346312 hasConceptScore W4313346312C2777637488 @default.
- W4313346312 hasConceptScore W4313346312C2781069245 @default.
- W4313346312 hasConceptScore W4313346312C501593827 @default.
- W4313346312 hasConceptScore W4313346312C523546767 @default.
- W4313346312 hasConceptScore W4313346312C54355233 @default.
- W4313346312 hasConceptScore W4313346312C71924100 @default.
- W4313346312 hasConceptScore W4313346312C86803240 @default.
- W4313346312 hasConceptScore W4313346312C89423630 @default.
- W4313346312 hasLocation W43133463121 @default.
- W4313346312 hasOpenAccess W4313346312 @default.
- W4313346312 hasPrimaryLocation W43133463121 @default.
- W4313346312 hasRelatedWork W1874411209 @default.
- W4313346312 hasRelatedWork W2037015070 @default.
- W4313346312 hasRelatedWork W2043577823 @default.
- W4313346312 hasRelatedWork W2890118735 @default.
- W4313346312 hasRelatedWork W2995814256 @default.
- W4313346312 hasRelatedWork W3032865068 @default.
- W4313346312 hasRelatedWork W3132092684 @default.
- W4313346312 hasRelatedWork W4291637776 @default.
- W4313346312 hasRelatedWork W4292552678 @default.
- W4313346312 hasRelatedWork W4385376231 @default.
- W4313346312 isParatext "false" @default.
- W4313346312 isRetracted "false" @default.
- W4313346312 workType "article" @default.